UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005221 |
|---|---|
| Receipt number | R000006203 |
| Scientific Title | A phase II study of pemetrexed plus carboplatin followed by pemetrexed maintenance therapy in chemotherapy-naive elderly patients with non-squamous non-small cell lung cancer |
| Date of disclosure of the study information | 2011/03/09 |
| Last modified on | 2019/10/10 09:52:04 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/03/09 14:41:09 | ||
| 2 | Update | 2012/03/09 13:28:59 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 3 | Update | 2013/04/02 15:35:00 | Email |
|
| 4 | Update | 2013/09/13 10:51:46 | Email Institutions |
|
| 5 | Update | 2013/09/13 10:53:13 | Key secondary outcomes Key secondary outcomes |
|
| 6 | Update | 2013/09/13 10:58:40 | Key inclusion criteria Key inclusion criteria |
|
| 7 | Update | 2013/09/13 10:59:48 | Last follow-up date |
|
| 8 | Update | 2014/03/19 11:50:29 | Last follow-up date |
|
| 9 | Update | 2016/02/25 10:47:40 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
| 10 | Update | 2017/09/19 09:46:37 | Last follow-up date |
|
| 11 | Update | 2018/03/14 12:46:05 | Recruitment status |
|
| 12 | Update | 2018/03/14 12:57:20 | Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
| 13 | Update | 2019/10/09 10:21:24 | Number of participants that the trial has enrolled Results |
|
| 14 | Update | 2019/10/09 10:24:52 | Recruitment status Date of IRB Last follow-up date |
|
| 15 | Update | 2019/10/09 10:32:14 | URL releasing protocol URL related to results and publications Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 16 | Update | 2019/10/09 10:33:03 | Results Baseline Characteristics Participant flow Adverse events Outcome measures |
|
| 17 | Update | 2019/10/09 10:47:41 | Recruitment status Last follow-up date |
|
| 18 | Update | 2019/10/10 09:51:08 | URL releasing protocol Results Baseline Characteristics Participant flow Adverse events Outcome measures |
|
| 19 | Update | 2019/10/10 09:52:04 | Recruitment status |
